Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 3,497.00
-296.00 (-7.80%)
May 29, 2026, 5:02 PM SAST
Dis-Chem Pharmacies Income Statement
Financials in millions ZAR. Fiscal year is March - February.
Millions ZAR. Fiscal year is Mar - Feb.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 42,826 | 39,172 | 36,283 | 32,664 | 30,407 | |
Revenue Growth (YoY) | 9.33% | 7.96% | 11.08% | 7.42% | 15.71% |
Cost of Revenue | 33,417 | 30,372 | 28,067 | 25,076 | 23,576 |
Gross Profit | 9,409 | 8,800 | 8,217 | 7,587 | 6,830 |
Selling, General & Admin | - | 1,307 | 1,212 | 984.49 | 803.97 |
Other Operating Expenses | 7,556 | 5,359 | 5,201 | 4,837 | 4,467 |
Operating Expenses | 7,556 | 6,696 | 6,437 | 5,843 | 5,291 |
Operating Income | 1,853 | 2,104 | 1,779 | 1,744 | 1,539 |
Interest Expense | -554.07 | -521.01 | -466.23 | -370.45 | -324.85 |
Interest & Investment Income | - | 30.4 | 26.3 | 20.21 | 12.1 |
Earnings From Equity Investments | 48.18 | 20.21 | 45.27 | 22.78 | 1.19 |
Other Non Operating Income (Expenses) | 47.5 | - | - | - | -0.63 |
EBT Excluding Unusual Items | 1,395 | 1,634 | 1,385 | 1,417 | 1,227 |
Pretax Income | 1,395 | 1,634 | 1,385 | 1,417 | 1,227 |
Income Tax Expense | 359.11 | 414.46 | 364.09 | 389.18 | 337.12 |
Earnings From Continuing Operations | 1,036 | 1,219 | 1,020 | 1,028 | 890.1 |
Minority Interest in Earnings | -56.72 | -39.43 | -36.01 | -27.32 | -36.66 |
Net Income | 978.89 | 1,180 | 984.48 | 1,000 | 853.45 |
Net Income to Common | 978.89 | 1,180 | 984.48 | 1,000 | 853.45 |
Net Income Growth | -17.03% | 19.84% | -1.57% | 17.20% | 27.63% |
Shares Outstanding (Basic) | 857 | 857 | 858 | 860 | 860 |
Shares Outstanding (Diluted) | 858 | 858 | 858 | 860 | 860 |
Shares Change (YoY) | -0.01% | -0.01% | -0.26% | -0.01% | 0.08% |
EPS (Basic) | 1.14 | 1.38 | 1.15 | 1.16 | 0.99 |
EPS (Diluted) | 1.14 | 1.38 | 1.15 | 1.16 | 0.99 |
EPS Growth | -17.02% | 19.88% | -1.38% | 17.24% | 27.55% |
Free Cash Flow | 1,213 | -25.46 | 863.11 | 230 | 1,459 |
Free Cash Flow Per Share | 1.41 | -0.03 | 1.01 | 0.27 | 1.70 |
Dividend Per Share | - | 0.548 | 0.457 | 0.466 | 0.397 |
Dividend Growth | - | 19.89% | -1.79% | 17.34% | 27.61% |
Gross Margin | 21.97% | 22.47% | 22.64% | 23.23% | 22.46% |
Operating Margin | 4.33% | 5.37% | 4.90% | 5.34% | 5.06% |
Profit Margin | 2.29% | 3.01% | 2.71% | 3.06% | 2.81% |
Free Cash Flow Margin | 2.83% | -0.07% | 2.38% | 0.70% | 4.80% |
EBITDA | 3,113 | 2,535 | 2,165 | 2,079 | 1,790 |
EBITDA Margin | 7.27% | 6.47% | 5.97% | 6.36% | 5.89% |
D&A For EBITDA | 1,260 | 431.38 | 386.14 | 334.64 | 250.5 |
EBIT | 1,853 | 2,104 | 1,779 | 1,744 | 1,539 |
EBIT Margin | 4.33% | 5.37% | 4.90% | 5.34% | 5.06% |
Effective Tax Rate | 25.75% | 25.37% | 26.30% | 27.47% | 27.47% |
Advertising Expenses | - | 632.6 | 637.81 | 521.39 | 394.22 |